InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Teper Daniel Gedeon. Director active across 1 company, notably IMMUNE PHARMACEUTICALS INC. Cumulatively, 4 disclosures have been recorded. Split: 4 buys · 0 sell. Regulator: SEC (Form 4). All data is openly available.
4 of 4 declarations